Compassionate use triple therapy CFTR modulation (Kaftrio®) in severe disease. Single-centre, real-world clinical outcomes, safety and tolerability

  • D Morrissy
  • , Y McCarthy
  • , J Dorgan
  • , C Fleming
  • , C Howlett
  • , T Vagg
  • , S Twohig
  • , B Plant

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalJournal of Cystic Fibrosis
Publication statusPublished - 2021

Cite this